<p>CMB = Classic medulloblastoma, DMB = Desmoplastic/nodular medulloblastoma, AMB = Large-cell/anaplastic medulloblastoma, SHH = SHH pathway medulloblastoma, WNT = WNT pathway medulloblastoma, Non-SHH/WNT = Non-SHH/WNT pathway medulloblastoma.</p>a<p>those patients who did not receive any adjuvant therapies after primary resection were excluded.</p
Medulloblastoma (MB) is the most common malignant brain tumor in children, where one-third of patien...
Background Recent transcriptomic approaches have demonstrated that there are at least 4 distinct sub...
PurposeReports detailing the prognostic impact of TP53 mutations in medulloblastoma offer conflictin...
<div><p>Medulloblastoma (MB) is one of the most common primary central nervous system tumors in chil...
Background Patients with incomplete surgical resection of medulloblastoma are controversially regard...
Medulloblastoma (MB) is the most common malignant pediatric posterior fossa tumor. Recent genetic, e...
Background: Patients with incomplete surgical resection of medulloblastoma are controversially regar...
Background: Patients with incomplete surgical resection of medulloblastoma are controversially regar...
BackgroundPatients with incomplete surgical resection of medulloblastoma are controversially regarde...
Background: Children with medulloblastoma have a 72% chance of surviving more than 5 years under cur...
Medulloblastoma (MDB) is the most common malignant paediatric brain tumor. Prognostic system based ...
PURPOSE OF REVIEW: The outcome of medulloblastoma patients and the quality of life of survivors can ...
Purpose: Medulloblastoma comprises four distinct molecular subgroups: WNT, SHH, Group 3, and Group 4...
Purpose Reports detailing the prognostic impact of TP53 mutations in medulloblastoma offer conflic...
Purpose: Microarray studies indicate medulloblastoma comprises distinct molecular disease subgroups,...
Medulloblastoma (MB) is the most common malignant brain tumor in children, where one-third of patien...
Background Recent transcriptomic approaches have demonstrated that there are at least 4 distinct sub...
PurposeReports detailing the prognostic impact of TP53 mutations in medulloblastoma offer conflictin...
<div><p>Medulloblastoma (MB) is one of the most common primary central nervous system tumors in chil...
Background Patients with incomplete surgical resection of medulloblastoma are controversially regard...
Medulloblastoma (MB) is the most common malignant pediatric posterior fossa tumor. Recent genetic, e...
Background: Patients with incomplete surgical resection of medulloblastoma are controversially regar...
Background: Patients with incomplete surgical resection of medulloblastoma are controversially regar...
BackgroundPatients with incomplete surgical resection of medulloblastoma are controversially regarde...
Background: Children with medulloblastoma have a 72% chance of surviving more than 5 years under cur...
Medulloblastoma (MDB) is the most common malignant paediatric brain tumor. Prognostic system based ...
PURPOSE OF REVIEW: The outcome of medulloblastoma patients and the quality of life of survivors can ...
Purpose: Medulloblastoma comprises four distinct molecular subgroups: WNT, SHH, Group 3, and Group 4...
Purpose Reports detailing the prognostic impact of TP53 mutations in medulloblastoma offer conflic...
Purpose: Microarray studies indicate medulloblastoma comprises distinct molecular disease subgroups,...
Medulloblastoma (MB) is the most common malignant brain tumor in children, where one-third of patien...
Background Recent transcriptomic approaches have demonstrated that there are at least 4 distinct sub...
PurposeReports detailing the prognostic impact of TP53 mutations in medulloblastoma offer conflictin...